Pharmaceutical Technology

MAY 2, 2024

Mergers and acquisitions (M&As) in the biopharmaceutical industry involving companies developing drugs showed a 20% increase in total deal volume in the first quarter (Q1) of 2024 compared to Q1 2023, according to leading data and analytics company GlobalData’s Pharma Intelligence Center Deals Database.

52

52

Express Pharma

MARCH 12, 2024

GlobalData’s Thematic Intelligence report, “The State of the Biopharmaceutical Industry 2024,” reveals that 44 per cent of healthcare professionals surveyed globally are optimistic or very optimistic about biotech funding recovery in the next 12 months. per cent to $1.86

103

103

Outsourcing Pharma

DECEMBER 7, 2023

The discussion centered around aritificial intelligence (AI) which have been the buzzwords in pharma and a number of other industries for at least the last year. OSP had a great conversation with Mike Connell, chief operating officer, at Enthought.

60

60

FDA Law Blog: Biosimilars

OCTOBER 16, 2023

Gonzalez — The Wall Street Journal (WSJ) recently published a series of articles as part of its special report “What’s Ahead for Artificial Intelligence.” Three of these articles focus on medical applications of Artificial Intelligence and Machine Learning (AI/ML) and explore FDA’s role in regulating such products.

Documentation 119

Documentation 119

Outsourcing Pharma

MAY 11, 2023

Helmholtz Munich, one of Germanyâs 19 research centers, that develops future solutions and technologies has selected DataDirect Networks (DDN) to accelerate its artificial intelligence (AI) driven discoveries.

52

52

Express Pharma

APRIL 22, 2024

billion in 2024, according to GlobalData’s Drugs Database Pharma Intelligence Center. billion in 2023, reveals GlobalData’s Drugs Database Pharma Intelligence Center. Mounjaro’s global sales reached $5.3 billion in 2023 and is forecasted to achieve $12.3 billion and $4.4 billion, respectively, in 2023.

Drug Pricing 102

Drug Pricing Diabetes Vaccines 102

Outsourcing Pharma

APRIL 12, 2023

A breakthrough in rectal cancer treatment has been discovered through a collaboration between a cancer intelligence company and the worldâs largest and oldest cancer center. It could put an end to the invasive surgery patients may have faced.

52

52

World Pharma News

JULY 3, 2023

Artificial intelligence can predict on- and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology.

66

66

Putting Patients First Blog

MAY 8, 2024

Leading health care experts asked health care providers and policymakers to keep patients of all ages at the center of their decision-making process during the National Health Council (NHC) 2024 Science of Patient Engagement Symposium. Rutta, NHC CEO. “By We promote increased access to affordable, high-value, sustainable health care.

Communication 52

Communication 52

Outsourcing Pharma

JUNE 24, 2021

The project will use the artificial intelligence specialistâs cell-centered models and deconvolutions to gain insights for each individual asthma endotype.

69

69

pharmaphorum

SEPTEMBER 28, 2020

The FDA has launched its Digital Health Center of Excellence (DHCoE), as the agency continues with its commitment to advancing use of technology such as mobile health devices, software and wearables to create medical products. The post FDA launches Digital Health Center of Excellence appeared first on.

141

141

Outsourcing Pharma

MARCH 8, 2022

The drug company has renewed its arrangement with the artificial intelligence specialist, centered on using AI to improve understanding of the immune system.

Immunity 52

Immunity Immunization 52

pharmaphorum

MAY 18, 2022

.” He was also involved in the creation of the FDA’s Digital Health Center of Excellence in 2020 and drawing up the Center for Devices and Radiological Health (CDRH) 2022-2025 strategic priorities, which covers much of the agency’s digital health plans.

135

135

Pharmaceutical Technology

FEBRUARY 8, 2023

trillion over the past year, according to GlobalData’s Pharma Intelligence Center Companies Database. billion for 2022, according to GlobalData’s Drugs Database Pharma Intelligence Center. for 2022 according to GlobalData’s Drugs Database Pharma Intelligence Center analyst consensus. trillion to $3.61

Vaccines 78

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 78

Pharmafile

FEBRUARY 27, 2023

Published date: 27/02/2023 Summary: Project to leverage vocal biomarkers for cognitive assessment of patients ages 55 and above in home environment PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Sonde Health , a health technology company committed (..)

Hospitals 52

Hospitals 52

Express Pharma

DECEMBER 28, 2023

As a part of it, eight centers of excellence for the diagnosis and treatment of rare diseases are established, along with additional testing centers and financial support for patients undergoing treatment. Despite these initiatives, rare diseases continue to be a pressing healthcare issue in India.”

Diabetes 97

Diabetes 97

Express Pharma

FEBRUARY 22, 2024

Takeda entered into multiple cell therapy collaborations for the development of CAR-T therapies with organisations like Memorial Sloan Kettering Cancer Center (MSK), Noile-Immune Biotech, and Crescendo Biologics in 2019 to advance the company’s novel immuno-oncology portfolio.

Immunity 103

Immunity Immunization 103

Express Pharma

APRIL 17, 2024

GlobalData’s Pharma Intelligence Center Deals Database reveals that MASH drugs secured over $5.7 Meanwhile, Novo Nordisk entered a $500 million co-development partnership deal with US-based Cellarity for the discovery and development of a small molecule drug for MASH using Cellarity’s artificial intelligence (AI) platform.

Drug Development 84

Drug Development Diabetes 84

Putting Patients First Blog

MARCH 14, 2024

A Recap of HLC 2024 March 14, 2024 By: Bhriana Onuoha, Senior Manager, Communications Last month, over 150 patient organizations, partners of patient organizations, business and industry representatives, and thought leaders networked in the sunny desert of Scottsdale, AZ, for the National Health Council’s (NHC’s) 2024 Health Leadership Conference.

Communication 59

Communication 59

Pharmaceutical Technology

MAY 11, 2023

Centers for Disease Control and Prevention, according to GlobalData’s analysis of social media posts. Notably, Covid-19 was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions ahead of innovation and artificial intelligence, according to GlobalData.

52

52

Express Pharma

MARCH 31, 2024

According to GlobalData’s Pharmaceutical Intelligence Center, from 2019 to 2023, 673 deals (strategic alliances) occurred among companies that are purely based in APAC, with 360 deals* of them being for unique therapy areas.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

DECEMBER 6, 2022

GlobalData’s Pharmaceutical Intelligence Center Companies Database found that 16 of the 20 top biopharmaceutical companies indicated a decline in quarter-on-quarter (QoQ) market capitalisation. percent from $3.45 trillion in Q2 2022 to $3.14 trillion in Q3 2022. Eight companies saw more than a 10 percent decline.

Vaccines 74

Vaccines Biosimilars 74

Express Pharma

DECEMBER 13, 2023

According to GlobalData’s Pharma Intelligence Center, while there is only one CAR-T therapy in Phase II and above pipeline in South Korea – anbalcabtagene autoleucel from Curocell, there are 217 CAR-T therapies in Phase II and above pipeline globally for various oncology indications.

Adverse Reactions 103

Adverse Reactions 103

Pharmaceutical Technology

MARCH 23, 2023

The biotech initial public offering (IPO) market saw a 79% decline in the number of completed IPOs from 2021 to 2022 in the US; however, this comes after the IPO boom in 2020 and 2021, according to GlobalData’s Pharma Intelligence Center Deals Database. Includes IPO deals for target companies located in the US.

Drug Development 59

Drug Development 59

Pharmaceutical Technology

APRIL 4, 2023

Source: GlobalData, Pharma Intelligence Center Drug Database (Accessed March 20, 2023). Source: GlobalData, Pharma Intelligence Center Drug Database (Accessed March 20, 2023). Source: GlobalData, Pharma Intelligence Center Drug Database (Accessed March 20, 2023). © GlobalData. ©GlobalData. ©GlobalData.

Vaccines 52

Vaccines Biosimilars 52

Express Pharma

DECEMBER 26, 2023

According to GlobalData’s Pharmaceutical Intelligence Center, the highest development phase of RNA-based therapies for the treatment of oncology is still Phase III for mRNA vaccines (mRNA-4157) and Phase II for both siRNA (lixadesiran with pixofisiran) and saRNA (MTL-CEBPA) drugs.

Vaccines 103

Vaccines 103

ID Stewardship

JUNE 6, 2023

In this article, ChatGPT weighs in on how pharmacists can use artificial intelligence. Welcome, fellow curious minds, to a captivating interview that promises to open doors to a world where artificial intelligence (AI) and the pharmaceutical profession unite in a delightful dance. Gauthier, Pharm.D., Let’s dive right in!

Insurance Coverage and Processing 52

Insurance Coverage and Processing Prescription Filling Hospitals Medication Dispensing 52

PharmaState Academy

DECEMBER 11, 2023

PharmaState.Academy in collaboration with Octavus Consulting organized a Masterclass on the Topic: Competitive Intelligence in the Pharma and Healthcare Landscape. Swati Sinha, CEO, PharmaState Academy Quick recap The meeting discussed the significance of Competitive Intelligence in the pharmaceutical industry.

Biosimilars 52

Biosimilars 52

Express Pharma

FEBRUARY 21, 2024

According to GlobalData’s Pharmaceutical Intelligence Center, between January 2019 and February 2024, 32 deals (Strategic alliances – excluding deals for co-development) for NMEs took place in India. Interestingly, six of those deals are involved in co-marketing of NMEs in India.

97

97

pharmaphorum

DECEMBER 2, 2022

Using data-informed insights derived by effectively implemented datasets, artificial intelligence/machine learning capabilities, and technology sponsors can realise increased predictability in their study planning from protocol design through enrolment strategy. Natalia Kotchie, vice president, R&DS Applied Data Science Center, IQVIA.

Compounding 98

Compounding Drug Development 98

Pharmaceutical Technology

JUNE 4, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Mayo Clinic 98

Mayo Clinic Hospitals Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

MAY 8, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Hospitals 98

Hospitals Pharmaceutical Companies Pharmaceutical Companies 98

Express Pharma

NOVEMBER 12, 2023

According to GlobalData’s Pharmaceutical Intelligence Center, the diagnosed prevalent cases of NASH in India are projected to increase from 10.7 It could be possibly because there was limited opportunity for such a partnership with an Indian pharma company due to the limited number of homegrown NCE drugs in their portfolio.”

Diabetes 102

Diabetes 102

Pharmaceutical Technology

NOVEMBER 15, 2022

Exscientia and The University of Texas MD Anderson Cancer Center in the US have entered a strategic partnership to use artificial intelligence (AI) to develop new cancer therapies.

Compounding 52

Compounding 52

European Pharmaceutical Review

MARCH 31, 2023

GlobalData Pharma Intelligence Center Deals Database found: SVB Financial Group and its subsidiaries were involved in more than $1.4 billion in total venture financing raised from 2010 to 2022 for drug development In 2018 alone, the company invested over $400 million in venture financing.

Drug Development 90

Drug Development 90

Integra X Files

JUNE 5, 2023

Public interest in artificial intelligence (AI) is exploding. Public figures , even the people at the forefront of designing AI systems, have expressed fear about what the future will hold in an age where AI systems take over tasks that have traditionally required human intelligence. What Is AI and Why Is It Different?

Nursing Homes 69

Nursing Homes 69

Express Pharma

NOVEMBER 1, 2023

According to GlobalData’s Pharmaceutical Intelligence Center, the number of 10-year diagnosed prevalent cases of Diffuse Large B-cell lymphoma (DLBCL) in India is expected to increase at an annual growth rate (AGR) of 1.7 This demands patients’ relocation to access these critical therapies, posing a significant challenge in India.”

92

92